000 01428 a2200433 4500
005 20250518090530.0
264 0 _c20200714
008 202007s 0 0 eng d
022 _a1545-5017
024 7 _a10.1002/pbc.28228
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRenzi, Samuele
245 0 0 _aBevacizumab for NF2-associated vestibular schwannomas of childhood and adolescence.
_h[electronic resource]
260 _bPediatric blood & cancer
_c05 2020
300 _ae28228 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aBevacizumab
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeurofibromin 2
_xmetabolism
650 0 4 _aNeuroma, Acoustic
_xdrug therapy
700 1 _aMichaeli, Orli
700 1 _aSalvador, Hector
700 1 _aAlderete, Daniel
700 1 _aPonce, Nicolas Fernandez
700 1 _aZapotocky, Michal
700 1 _aHansford, Jordan R
700 1 _aMalalasekera, Vajiranee S
700 1 _aToledano, Helen
700 1 _aMaguire, Bryan
700 1 _aBouffet, Eric
700 1 _aRamaswamy, Vijay
700 1 _aBaroni, Lorena V
773 0 _tPediatric blood & cancer
_gvol. 67
_gno. 5
_gp. e28228
856 4 0 _uhttps://doi.org/10.1002/pbc.28228
_zAvailable from publisher's website
999 _c30698230
_d30698230